… 1001 0·5% or WBI‐1001 1·0% in a cream formulation applied twice daily for 6 weeks. At the end of this phase, patients receiving WBI‐1001 … 1001 (at 0·5% and 1·0%) in patients with AD. …
By using an agar dilution method, the comparative in vitro activities of ertapenem (MK-0826) were studied against 1,001 anaerobes isolated from human intra-abdominal infections in 17 …
Objective: Our goal was to compare the accuracy of the amniotic fluid index and the 2-diameter pocket technique with respect to accuracy in predicting an adverse pregnancy outcome …
The ebook is easy in go through easier to recognize. We have study and i am certain that i will planning to read through once again once again in the future. I am quickly will get a …
Objective: This randomized, phase II, multicenter clinical trial was conducted to evaluate the feasibility of laparoscopy-assisted distal gastrectomy (LADG) with D2 lymph node dissection …
Most mammalian cell types have the potential to assemble at least one cilium. Immotile cilia participate in numerous sensing processes, while motile cilia are involved in cell motility and …
Large-scale computing technologies have enabled high-throughput virtual screening involving thousands to millions of drug candidates. It is not trivial, however, for biochemical …
… This was a multicenter, open-label, dose-escalation, phase I study of DS-1001 for recurrent/progressive IDH1-mutant (R132) glioma (N = 47) (NCT03030066). DS-1001 was …
Aims Psychological comorbidity among children with functional incontinence is high: 20–30% of children with nocturnal enuresis (NE), 20–40% of those with daytime urinary …
… of the PARP inhibitor INO-1001 on aging-associated cardiac and … after a single injection of INO-1001. Endothelium-dependent and -… Single dose INO-1001-treatment resulted in acute …